Join
Live feed
·
INSIDERFilingvia Quantisnow
Biomea Fusion Inc. logo

SEC Form 4: A2a Pharmaceuticals, Inc. sold $407,578 worth of shares (34,658 units at $11.76), decreasing direct ownership by 0.79% to 4,365,342 units

ByQuantisnow·Wall Street's wire, on your screen.
BMEA· Biomea Fusion Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMEA (Biomea Fusion Inc.) and more on Quantisnow.